BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16794157)

  • 1. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response.
    Mayr NA; Yuh WT; Taoka T; Wang JZ; Wu DH; Montebello JF; Meeks SL; Paulino AC; Magnotta VA; Adli M; Sorosky JI; Knopp MV; Buatti JM
    AJR Am J Roentgenol; 2006 Jul; 187(1):65-72. PubMed ID: 16794157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
    Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
    AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
    Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
    Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
    van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia.
    Lim K; Chan P; Dinniwell R; Fyles A; Haider M; Cho YB; Jaffray D; Manchul L; Levin W; Hill RP; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):126-33. PubMed ID: 17768016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of tumor size on MR imaging in assessing the prognosis of uterine cervical cancer treated with radiation].
    Hayashi T; Kato T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 May; 59(6):250-5. PubMed ID: 10388310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer.
    Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Sorosky JI; Magnotta VA; Pelsang RE; Hussey DH
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):395-404. PubMed ID: 9308943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of magnetic resonance tomography after primary irradiation of carcinoma of the cervix uteri: evaluation of therapeutic success and follow-up].
    Flückiger F; Ebner F; Poschauko H; Arian-Schad K; Einspieler R; Hausegger K
    Strahlenther Onkol; 1991 Mar; 167(3):152-7. PubMed ID: 2014471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer.
    Mayr NA; Wang JZ; Zhang D; Montebello JF; Grecula JC; Lo SS; Fowler JM; Yuh WT
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1513-21. PubMed ID: 19286329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer: serial MR imaging before and after primary radiation therapy--a 2-year follow-up study.
    Flueckiger F; Ebner F; Poschauko H; Tamussino K; Einspieler R; Ranner G
    Radiology; 1992 Jul; 184(1):89-93. PubMed ID: 1609108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MR imaging-evaluation of therapeutic effect of radiotherapy for uterine cervix cancer].
    Kitagaki H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Mar; 55(4):215-21. PubMed ID: 7746721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.